Plasma Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Acute Myocardial Infarction

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 2, 2002-07 ,pp. : 80-84

Karger

Access to resources Recommend Favorite

Effects of the Magenstrasse and Mill Operation for Obesity on Plasma Plasminogen Activator Inhibitor Type 1, Tissue Plasminogen Activator, Fibrinogen and Insulin

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 40-43

Karger

Access to resources Recommend Favorite

The Safety and Efficacy of Low‐dose Tissue Plasminogen Activator in the Treatment of Systemic Sclerosis

By  

THE JOURNAL OF DERMATOLOGY, Vol. 22, Iss. 9, 1995-09 ,pp. : 637-642

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nattokinase-Promoted Tissue Plasminogen Activator Release from Human Cells

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 5, 2009-12 ,pp. : 227-232

Karger

Access to resources Recommend Favorite

A synthetic peptide derived from staphylokinase enhances plasminogen activation by tissue‐type plasminogen activator

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 9, Iss. 5, 2011-05 ,pp. : 997-1006

John Wiley & Sons Inc

Access to resources Recommend Favorite